focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Synthomer lifts outlook on strong momentum

Mon, 19th Jul 2021 07:47

(Alliance News) - Stocks in London are set to start the week on the back foot amid concerns over rising coronavirus cases across the globe.

In early UK company news, Ultra Electronics unveiled a jump in interim profit in a stronger-than-expected set of results, Synthomer boosted its 2021 earnings guidance, and AstraZeneca's Imfinzi received Chinese approval.

IG says futures indicate the FTSE 100 to open down 57.49 points, or 0.8%, at 6,950.60 on Monday. The index of large-caps closed down 3.93 points, or 0.1%, at 7,008.09 on Friday.

The soft start for London follows a weak performance for equities in Asia on Monday.

In Tokyo, the Nikkei 225 index ended down 1.3%. In China, the Shanghai Composite was flat, while the Hang Seng index in Hong Kong was down 1.7%. The S&P/ASX 200 in Sydney ended down 0.9%.

In the US on Friday, Wall Street also had ended lower, with the Dow Jones Industrial Average down 0.9%, the S&P 500 down 0.8%, and the Nasdaq Composite down 0.8%.

"Equity markets are front and centre in Asia this morning, as increasing nerves about the delta-variant Covid-19 are sapping recovery hopes across the Asia-Pacific. Of course, you can choose your poison on that front globally, with the US, Europe, and the UK also experiencing rises in cases," said Jeffrey Halley, senior market analyst at Oanda.

Despite daily coronavirus cases surging, the UK government on Monday lifted pandemic restrictions on daily life in England, scrapping all social distancing in a step slammed by opposition parties and some scientists as a dangerous leap into the unknown.

From midnight, nightclubs were able to reopen and other indoor venues allowed to run at full capacity, while legal mandates covering the wearing of masks and working from home were scrapped.

UK Prime Minister Boris Johnson – who is self-isolating after his health minister was infected – urged the public to remain prudent and for any laggards to join the two-thirds of UK adults who are now fully vaccinated.

He defended the reopening – dubbed 'freedom day' by some media – despite some scientists' misgivings after daily infection rates in Britain topped 50,000, behind only Indonesia and Brazil.

Oanda's Halley said he expects "nerves" over the reopening decision to cap gains for sterling this week.

The pound was quoted at USD1.3751 early Monday, slipping from USD1.3788 at the London equities close on Friday.

In early UK company news, AstraZeneca said its Imfinzi has been approved in China for the treatment of extensive-stage small cell lung cancer.

Small cell lung cancer is a highly aggressive, fast-growing form of lung cancer, Astra said. The approval by China's National Medical Products Administration was based on positive results from the Caspian phase three trial, with safety and efficacy in the China cohort of patients consistent with the global results.

Ultra Electronics reported a stronger-than-expected first half, leaving the aerospace and defence engineering company confident on its prospects.

Revenue for the six months to July 2 slipped 2.1% to GBP404.5 million from GBP413.1 million a year before. However, on an organic basis, revenue rose 4.7%.

The revenue performance was a strong one "particularly given the mainly Covid-19 driven operational inefficiencies and supply chain disruption experienced in Q1 2021, which are now broadly resolved."

Pretax profit jumped 55% to GBP46.2 million from GBP29.8 million.

Looking ahead, Ultra Electronics said its focused strategy and improved execution allows for increased confidence in delivering above-market growth.

Chief Executive Simon Pryce said: "Our Focus; Fix; Grow transformation programme is already delivering ahead of plan and we are now more confident in our improvement potential with a better payback than originally anticipated. This should allow us to accelerate top-line growth and gain market share through additional investment in research & development, improved operational delivery and by further optimising our cost base."

Synthomer boosted its 2021 earnings guidance following good trading momentum in its first half.

The chemicals company said it has continued to see strong trading momentum across the business with volumes and unit margins ahead of a year ago in all divisions. The Nitrile latex business has been performing well, it added, driven by "exceptional demand" due to the pandemic.

As a result, Synthomer now expects 2021 earnings before interest, tax, depreciation and amortisation in excess of GBP500 million, compared to its previous guidance of above GBP450 million. In 2020, the company recorded Ebitda of GBP259.4 million.

"Synthomer continues to expect that the Nitrile latex business will return to more normalised levels during 2022," it added.

All Active Asset Capital said it is in "constructive discussions" with Audioboom about a possible offer for the podcasts producer at GBP12.00 per share.

If an offer is made, AAA said, it would consist of 12.5 new AAA shares and 200p in cash per Audioboom share. This would value Audioboom shares at GBP12.00 each, a premium of 36% to Friday's closing price of 885p.

AAA has received irrevocable undertakings to accept such an offer in respect of 4.1 million Audioboom shares, representing 26% of its share capital.

"The directors believe the combination of AAA and Audioboom would create a compelling portfolio of innovative, high growth technology investments that could create significant new accretive value for the shareholders of both companies in the future," said AAA.

There can be no certainty that any firm offer will be made, it stressed.

Separately, AAA said that Allenby has resigned as nominated advisor and broker due to a conflict of interest. AAA shares remain suspended, and it has one month to appoint a new nomad under AIM rules.

The euro traded at USD1.1803 early Monday, soft on USD1.1810 late Friday. Against the safe-haven Japanese yen, the dollar fell to JPY109.96 versus JPY110.15.

Gold was quoted at USD1,806.16 an ounce early Monday, down against USD1,813.55 on Friday.

Brent oil was trading at USD73.00 a barrel, soft on USD73.27 late Friday after the world's leading oil producers agreed on Sunday to continue to modestly boost output from August.

In a rare challenge to OPEC leader Saudi Arabia, the UAE had rejected a proposed deal earlier this month as "unjust", leading to a stalemate. But in a compromise, Sunday's discussions agreed to adjust output quotas next May for the UAE, Iraq, Kuwait, Russia and Saudi Arabia itself, meaning their actual cuts will be less.

Saudi Energy Minister Prince Abdulaziz bin Salman, who chairs the OPEC group, declined to say how the new quotas were decided and beneficiaries chosen, saying it had been part of "consensus building".

The economic events calendar on Monday has eurozone construction output at 1000 BST.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.